Table 3.

Primers Used for ChIP

Promoter	Primers
Negative control	5′-ATGGTTGCCACTGGGGATC-3′	Forward
	5′-TGCCAAAGCCTAGGGGAAGA-3′	Reverse
PLA2G4C	5′-ATGGCTCCACCAGGTAGGTA-3′	Forward
	5′-AGCTCATGAGGCTCTCCACA-3′	Reverse
FLAP	5′-CAGTGGTCCATGTTCCCTTT-3′	Forward
	5′-AGGTGGCTGCCTGGTATTCT-3′	Reverse
RhoB	5′-ACAGGCATGAGGTACTGTGC-3′	Forward
	5′-CGGTCTCTGTCAGTTGTTG-3′	Reverse
MMP-10	5′-TACCAAGCTTGTCAGCTCTG-3′	Forward
	5′-GGTGATACAGCCTACATCAG-3′	Reverse
MMP-1	5′-AATGCTGCCTAGCACCAAGG-3′	Forward
	5′-AGAGCCTTACCTGAGAAGAC-3′	Reverse
PAI-1	5′-AGGCAGGAGAACCACTTGAA-3′	Forward
	5′-ACTGGCTAGCAGTGGGTGAG-3′	Reverse
CX3CL1	5′-CTTCGGTGAGAGCCTGTTG-3′	Forward
	5′-CCCTGTTAGCCCAAAGAACA-3′	Reverse
eNOS	5′-TGGTGCCACATCACAGAAGG-3′	Forward
	5′-TCTAAAGCCTCAGCTCCACG-3′	Reverse
EDNRA	5′-CGCTGGAACCTTCCATAGTC-3′	Forward
	5′-AAGCTTAGAGGCCGTTGAGG-3′	Reverse
ET-1	5′-ATCTCCCCCTGGTGTTCTTC-3′	Forward
	5′-TTAGGCACATGCCCAGTCTT-3′	Reverse
VE-Cadherin	5′-GGTTCTTCTGGGCTCTGATC-3′	Forward
	5′-GGATATTGGGTGGAGTCAAG-3′	Reverse

ChIP, chromatin immunoprecipitation.